Sumitomo Pharma Co (TSE:4506) FFO


TSE:4506 Sumitomo Pharma Co Ltd TSE:4506
56 GF Score
Price 円1,529.00
GF Value 円827.78
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sumitomo Pharma Co FFO?

FFO (Funds from operations) only applies to REITs.

TSE:4506
56GF Score
Sumitomo Pharma Co Ltd TSE:4506
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sumitomo Pharma Co (TSE:4506) Overvalued in 2026?

Based on GuruFocus' analysis, Sumitomo Pharma Co stock appears to be overvalued. The current stock price of 円1,529.00 is trading 84.7% above its estimated GF Value™ of 円827.78. GuruFocus considers Sumitomo Pharma Co to be Significantly Overvalued.

Key valuation signals for TSE:4506:

  • FFO:
  • GF Value™: 円827.78 vs. price of 円1,529.00 (84.7% above fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the TSE:4506 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sumitomo Pharma Co Business Description

Address 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
56GF Score

Get the complete analysis for TSE:4506

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,529.00
Price
円827.78
GF Value